Frequency of TERT promoter mutations in human cancers

Vinagre, João, Almeida, Ana, Pópulo, Helena, Batista, Rui, Lyra, Joana, Pinto, Vasco, Coelho, Ricardo, Celestino, Ricardo +16 more·2013·Nature Communications
DOI 10.1038/ncomms3185

Cited by (886)

Items 701–800 of 886

  1. Extremely aggressive course in a poorly differentiated thyroid carcinoma presenting a double mutation of the TERT promoter
    Denise Engelbrecht Zantut‐Wittmann, Ana Carolina Laus, Daniel Antunes Moreno, Icléia Siqueira Barreto, Camila Aparecida Moma, F.F.R. Maia, E. C. S. de C. Etchebehere, Lígia Vera Montali da Assumpção, Rui Manuel Reis · 2023 · The American Journal of the Medical Sciences
  2. Thyroid Cancer, Iodine, and Gene Mutation
    Jae Hoon Chung · 2023 · International Journal of Thyroidology
  3. Minor role of TP53 and TERT promoter mutations in medullary thyroid carcinoma: report of new cases and revision of the literature
    Roberta Casalini, Cristina Romei, Raffaele Ciampi, Teresa Ramone, Alessandro Prete, Carla Gambale, Antonio Matrone, Liborio Torregrossa, Clara Ugolini, Rossella Elisei · 2024 · Endocrine
  4. Catching the Silent Culprits: TERT Promoter Mutation Screening of Minimally Invasive Follicular and Oncocytic Thyroid Carcinoma in Clinical Practice
    L. Samuel Hellgren, Adam Stenman, Kenbugul Jatta, Vincenzo Condello, Catharina Larsson, Jan Zedenius, C. Christofer Juhlin · 2024 · Endocrine Pathology
  5. Clinicopathologic and genomic characteristics of biliary tract carcinomas with TERT promoter mutations among East Asian population
    Inwoo Hwang, So Young Kang, Deok Geun Kim, Kee‐Taek Jang, Kyoung‐Mee Kim · 2024 · Pathology - Research and Practice
  6. Telomeres and telomerase in mesothelioma: Pathophysiology, biomarkers and emerging therapeutic strategies (Review)
    Dimitrios Andreikos, Demetrios A. Spandidos, Vasiliki Georgakopoulou · 2025 · International Journal of Oncology
  7. Targeted Mutational Profiling and a Powerful Risk Score as Additional Tools for the Diagnosis of Papillary Thyroid Cancer
    Barbara Kocsis-Deák, Kristóf Árvai, Bernadett Balla, Bálint Tóbiás, Andrea Kohánka, Balázs Járay, János Horányi, János Podani, István Takács, Zsuzsanna Putz et al. · 2019 · Pathology & Oncology Research
  8. A hypothesis-generating analysis on the role of TERT promoter mutation in advanced urothelial carcinoma treated with immunotherapy.
    Paola Valeria Marchese, Veronica Mollica, Dario de Biase, Francesca Giunchi, Elisa Tassinari, Andrea Marchetti, Matteo Rosellini, Giacomo Nuvola, Thais Maloberti, Michelangelo Fiorentino et al. · 2022 · Pathology - Research and Practice
  9. Interrogation of TERT promoter hotspot mutations in ameloblastoma and ameloblastic carcinoma
    Maria Carolina Silva Versieux Magalhães, Fernanda Aragão Felix, Letícia Martins Guimarães, Jean Nunes dos Santos, Luiz Armando De Marco, Ricardo Santiago Gomez, Carolina Cavaliéri Gomes, Sílvia Ferreira de Sousa · 2022 · Journal of Oral Pathology and Medicine
  10. An overview of the role of telomeres and telomerase in pre‑neoplastic lesions (Review)
    Eleftheria Karaviti, Athanasios Kontogiannis, Aristotelis Anastopoulos, Elias Alexandros Kotteas, Georgia Gomatou · 2023 · Molecular and Clinical Oncology
  11. Molecular biology of papillary thyroid microcarcinomas: What is new?
    Bárbara Neto Castro, Elisabete Rodrigues · 2016 · Revista Portuguesa de Endocrinologia Diabetes e Metabolismo
  12. Cancer RNome: Evolution and Sustenance
    Mansi Arora, Deepak Kaul · 2018 · Springer eBooks
  13. Mechanisms of telomere maintenance in pediatric brain tumors: Promising targets for therapy – A narrative review
    Felice Giangaspero, Simone Minasi, Francesca Gianno, Hiba Alzoubi, Manila Antonelli, Francesca Romana Buttarelli · 2020 · Glioma
  14. Regulatory Single Nucleotide Polymorphism Increases TERT Promoter Activity in Thyroid Carcinoma Cells
    Tatsuya Hirokawa, Yuu Arimasu, Tomohiro Chiba, Yoko Nakazato, Masachika Fujiwara, Hiroshi Kamma · 2020 · Pathobiology
  15. Melanoma-derived induced pluripotent stem cells
    Edgardo Castro‐Pérez, Shreyans Sadangi, Mithalesh Kumar Singh, Vijayasaradhi Setaluri · 2021 · Elsevier eBooks
  16. Telomeres and Telomerase in Ageing and Cancer
    Michel M. Ouellette · 2018 · Wiley eBooks
  17. Uromonitor ® as a novel sensitive and specific urine-based test for recurrence surveillance of patients with non-muscle invasive bladder cancer
    Cristina Sampaio, Rui Batısta, João Pedro Peralta, Paulo Conceição, Amílcar Sismeiro, Hugo Prazeres, João Vinagre, Paula Soares · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  18. Case report: Pulmonary Ewing sarcoma disguised as non-small cell lung cancer
    Mary E. Carter, Alessia Benegiamo-Chilla, Linus D. Kloker, Nikolas Paulsen, Vlatko Potkrajcic, Frank Paulsen, Attila Németh, Volker Steger, Martin Schulze, Saskia Biskup et al. · 2024 · Frontiers in Oncology
  19. Telomere Dynamics in Cardiovascular Aging: From Molecular Mechanisms to Precision Medicine
    Abbas Mohammadi, Daniel Thomas Jones, Somayeh Mohammadi, Giv Heidari‐Bateni, William H. Frishman, Wilbert S. Aronow · 2025 · Cardiology in Review
  20. Programmable DNA‐Based Synthetic Organelles as Telomerase Traps for Cell Cycle Regulation in Cancer Cells
    Yanfei Guo, Siqi Li, Zhaoyue Lv, Yan Hua Huang, Peiran Li, Cheng Yu, Chi Yao, Dayong Yang · 2025 · Advanced Functional Materials
  21. Genome‐wide analysis of somatic noncoding mutation patterns and mitochondrial heteroplasmic shift in type B1 and B2 thymomas
    Kohei Fujikura, Isabel Correa, Susanne Heck, Kaoru Watanabe, Juliet Elizabeth King, Emma McLean, Susan Ndagire, Yoshihisa Takahashi, Masahiko Kuroda, Andrea Billè et al. · 2025 · The Journal of Pathology
  22. Metabolic dependencies and neural progenitor dysregulation: driving forces in paediatric high-grade glioma development
    Yan Hay Grace Lee, Maria Tsoli, Yan Chuan Shi, Chi Kin Ip, David Ziegler · 2026 · Cancer and Metastasis Reviews
  23. Diagnostic and Prognostic Molecular Markers in Thyroid Cancer
    Mingzhao Xing · 2016 · Springer eBooks
  24. Nomogram of magnetic resonance imaging (MRI) histogram analysis to predict telomerase reverse transcriptase promoter mutation status in glioblastoma
    Bin Zhang, Qing Zhou, Caiqiang Xue, Xiaoai Ke, Peng Zhang, Tao Han, Liangna Deng, Mengyuan Jing, Junlin Zhou · 2024 · Quantitative Imaging in Medicine and Surgery
  25. Update on Somatic Genomic Alterations in Follicular Cell-Derived Thyroid Cancers
    William R. Perry, Thomas J. Giordano · 2025 · Endocrinology and Metabolism Clinics of North America
  26. Genomic Signatures of Risk Factors and Molecular Identification of HCC Subtypes
    Jean‐Charles Nault, Jessica Zucman‐Rossi · 2016 · Springer eBooks
  27. Evaluation of possible role of the hTERT gene rs2853669 polymorphism in the development of colorectal cancer as a genetic risk factor
    Berrin Yalınbaş Kaya, Yakup Ülger · 2022 · Nucleosides Nucleotides & Nucleic Acids
  28. Comparison of TERT and 5-Hydroxymethylcytocine immunohistochemistry in various thyroid carcinomas
    Hyeong Rok An, Won Gu Kim, Yu‐Mi Lee, Tae‐Yon Sung, Dong Eun Song · 2024 · Annals of Diagnostic Pathology
  29. Telomerase: a nexus between cancer nanotherapy and circadian rhythm
    Pramit Kumar Ghosh, Maddila Jagapathi Rao, Chandra Lekha Putta, Sandipan Ray, Aravind Kumar Rengan · 2024 · Biomaterials Science
  30. Neo‐enhancers in T‐cell acute lymphoblastic Leukaemia (T‐ ALL ) and beyond
    Charlotte L. Smith, Vahid Asnafi, Aurore Touzart · 2025 · International Journal of Cancer
  31. SDHD promoter mutations are rare events in cutaneous melanomas but SDHD protein expression is downregulated in advanced cutaneous melanoma
    Helena Pópulo, Rui Batısta, Cristina Sampaio, Joana Pardal, José Manuel Lopes, Paula Soares · 2017 · PLoS ONE
  32. Exploration of regression models for cancer noncoding mutation recurrence
    Tanjin Xu, Stephen A. Ramsey · 2016 · ACM International Conference on Bioinformatics, Computational Biology, and Health Informatics (ACM-BCB)
  33. Molecular Pathology and Genomics of Melanoma
    Klaus Griewank, Rajmohan Murali, Thomas Wiesner · 2018 · Springer eBooks
  34. The prospect of discovering new biomarkers for ovarian cancer based on current knowledge of�susceptibility loci and genetic variation (Review)
    Mikael Kronborg Christophersen, Claus Kim Høgdall, Estrid Vilma Solyom Høgdall · 2019 · International Journal of Molecular Medicine
  35. Co-Occurrence of Hotspot Point Mutation and Novel Deletion Mutation of TERT Promoter in Solid Variant Papillary Thyroid Carcinoma in a Patient with Synchronous Esophageal Cancer
    Jiheun Han, Young Lyun Oh, Jung-Sun Kim · 2020 · Diagnostics
  36. Perfiles mutacionales de carcinoma escamoso de pene en cuatro pacientes paraguayos
    David Olivares, María Luisa Cabañas, Arnaldo Vázquez, Luis Benítez, Óscar Núñez, Cinthia Gauna, María Lucila González Donna · 2022 · Oncología Clínica
  37. Dual Age-dependent function of KLF4 in Wnt regulation linked with TERT and Ctnnb1 in two differentiated and undifferentiated populations of SSCs
    Kiana Sojoudi, Hossein Azizi, Thomas Skutella · 2022 · Research Square
  38. Ultraviolet Radiation and Melanoma
    Thomas M. Rünger · 2019 · Springer eBooks
  39. The Safety of Oral Telomerase Activator in UV-Induced Skin Cancer with A Review of Telomerase in Aging and Skin Carcinogenesis
    Karen Burke, Xueyan Zhou, Yongyin Wang, Huachen Wei · 2021 · OBM Geriatrics
  40. Development of 3D Cell-Based Fluorescent Reporter Assay for Screening of Drugs Downregulating Telomerase Reverse Transcriptase
    You Li, Fengli Zhang, Zhen Qin, Shang‐Tian Yang · 2025 · Bioengineering
  41. Methylation Status of the Telomerase Reverse Transcriptase Promoter in Parotid Tumours and Adjacent Parotid Gland Tissue: A Pilot Study on the Implications for Recurrence and Development of Malignancy
    António Paiva‐Correia, Joana Dias Apolónio, Alfons Nadal, José Ricardo Brandão, Nádia Silva, Bianca Machado, Iván Archilla, Pedro Castelo‐Branco, Henrik B. Hellquist · 2025 · Current Oncology
  42. Discovery and Validation of an Ancillary Genomic Test of Malignancy for Primary Melanocytic Tumors
    Ismael A. Vergara, Nigel Gordon Maher, Alison J. Potter, Elizabeth C. Paver, Jordan W. Conway, Serigne Lo, Andrew J. Colebatch, Georgina Venetia Long, James S. Wilmott, Richard A. Scolyer · 2025 · Clinical Cancer Research
  43. Blocking interplay between TERT and c-Myc: a new therapeutic strategy for BRAFV600E/pTERT double mutated tumors
    Jing Wei, Jiazhe Liu, Yan Zhang, Guobin Wang, Xiao Cui, Wei Yu, Chunlei Nie, Peng Hou · 2025 · International Journal of Biological Sciences
  44. Stratification of telomerase activity in cancer reveals associations with senescence and genomic instability
    Nighat Noureen, Min H. Kang · 2025 · Computational and Structural Biotechnology Journal
  45. Long-Read Amplicon Sequencing for the Detection of TERT Promoter Variant Clonal Hematopoiesis in Patients with Telomere Biology Disorders
    R Kirchner, Miguel Pereira, Madilynn Peterson, Mark E. Berres, Jane E. Churpek · 2026 · Journal of Molecular Diagnostics
  46. Value of TERT promoter mutations for early outcomes in papillary thyroid cancer
    Min Jhi Kim, Daham Kim, Hye Sun Lee, Se Hee Park, Eun Jin Kim, Jin Kyong Kim, S M Kang, Jandee Lee, Jong Ju Jeong, Woong Youn Chung et al. · 2026 · Endocrine Related Cancer
  47. Characterizing selection signatures in coding and noncoding regions of 14,886 cancer genomes
    Mengyue Zheng, Xiwei Sun, Junren Hou, Minmin Guo, Xinran Liu, Wen Yang, Jian Yang · 2026 · Journal of genetics and genomics/Journal of Genetics and Genomics
  48. Prognostic Role of TERT Mutations in Chondrosarcoma: Associations with Dedifferentiation, Survival, and IDH/TERT Co-Mutations
    Alyan Zafar, Daisy A. Ference, Brooke M. Crawford, Sergio José Torralbas Fitz, Francis John Hornicek, Harry Thomas Temple · 2026 · Cancers
  49. Convergent Mechanistic Pathways Driving the Anaplastic Phenotype in Thyroid Cancer
    Anthony J. Centone, Nicole R. DeSouza, Nan Yang, Shaun Desai, Augustine L. Moscatello, David A. Garber, Steven A. Hemmerdinger, Janine M. Rotsides, Mike Yao, Raj K. Tiwari et al. · 2026 · International Journal of Molecular Sciences
  50. Insights from Genetic Models of Melanoma in Fish
    Viviana Anelli, Nicole Zettler, Marina Mione · 2014 · Current Pathobiology Reports
  51. Ultraviolet Radiation and Melanoma
    Thomas M. Rünger · 2017 · Springer eBooks
  52. An Overview of Molecular Genetics of Brain Tumors
    Brian J. Scott, Santosh Prasad Kesari · 2018 · Elsevier eBooks
  53. Current and future markers for the diagnosis of thyroid cancer
    DESCAMPS Géraldine, Fabrice Journé, Saussez Sven · 2019 · Clinical Oncology and Research
  54. Pathogenesis of Thyroid Carcinoma
    Massimo Santoro, Francesca Carlomagno · 2018 · Endocrinology
  55. Lack of Telomerase Reverse Transcriptase Promoter C228T and C250T Hotspot Mutations in Colorectal Cancer Patients in Türkiye
    Turkan Gurer, Nisreen AL DOORI · 2022 · Journal of Oncological Sciences
  56. Melanoma and Glioblastoma—Not a Serendipitous Association
    Kei Shing Oh, Meera Mahalingam · 2023 · Advances in Anatomic Pathology
  57. Gamma-glutamyl cyclotransferase, a molecule identified from the invasive front of follicular thyroid carcinoma, is useful for differential diagnosis of follicular thyroid tumors
    T. Mitsuhashi, Sachiko Ogasawara, Masamichi Nakayama, Reiichiro Kondo, Jun Akiba, Kenta Murotani, Takeharu Ono, Fumihiko Satô, Hirohito Umeno, Hirohisa Yano · 2024 · Pathology - Research and Practice
  58. Regulation of Telomerase in Normal and Cancer Stem Cells
    I Lam Chan · 2024 · International Conference on Bioinformatics Research and Applications (ICBRA)
  59. On the Far Side of Telomeres: The Many Roles of Telomerase in the Acquisition and Retention of Cancer Stemness
    Kerem Teralı, Açelya Yılmazer · 2016 · InTech eBooks
  60. The Role of Telomeres and Telomere-associated Proteins as Components of Interactome in Cell-signaling Pathways
    Ekta Khattar, Vinay Tergaonkar · 2016 · InTech eBooks
  61. Pathogenesis of Thyroid Carcinoma
    Massimo Santoro, Francesca Carlomagno · 2016 · Endocrinology
  62. Pediatric High Grade Glioma
    Chitra Sarkar, Suvendu Purkait, Pankaj Pathak, Prerana Jha · 2017 · Current cancer research
  63. BRAF V600E/TERT promoter mutations and NIS/TSHR expression in differentiated thyroid carcinoma and their clinical significance ⁎
    Ru Xiaoting, Qinjiang Liu, Haihong Zhou, Rong Yang, Lie Bao · 2017 · Oncology and Translational Medicine
  64. Thyroid and Parathyroid Glands
    Catarina Eloy, Paula Soares, Valdemar Máximo, Manuel A. Sobrinho-Simões · 2016 · Springer eBooks
  65. A Noncanonical Function of the Telomerase RNA Component in Human Embryonic Stem Cells
    Kirsten Ann Brenner · 2020 · Open Scholarship Institutional Repository (Washington University in St. Louis)
  66. A Hepatocellular Carcinoma Patient with TSC1 Mutations Benefits from Treatment with Everolimus: A Case Report
    Huasheng Shi, Shuo Wang, Manjiang Li, Liqun Wu · 2020 · Visceral Medicine
  67. Molecular Pathology and Genomics of Melanoma
    Klaus Griewank, Rajmohan Murali, Thomas Wiesner · 2020 · Springer eBooks
  68. Telomerase and Its Therapeutic Implications in Cancer
    Raman Kumar, Nidhi Gupta, Alpana Sharma · 2022 · Springer eBooks
  69. Genetic insights on the role of telomere dynamics in Chronic Kidney Disease (CKD) regardless of HIV status
    Sibusiso Tebogo Malindisa · 2016
  70. BreakCA, a method to discover indels using ChIP-seq and ATAC-seq reads, finds recurrent indels in regulatory regions of neuroblastoma genomes
    Arko Sen, Sélène T. Tyndale, Yi Fu, Galina A. Erikson, Graham McVicker · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  71. [Non-venereal penile cord induration. Is it a lymphangitis or a phlebitis?].
    C Aguilera Maruri · 1964 · PubMed
  72. Molecular markers as risk factors for thyroid cancer
    M. O. Rogova, S.V. Novosad, Narine S. Martirosian, Liubov V. Trukhina, Nina Alexandrovna Petunina · 2019 · Terapevticheskii arkhiv
  73. A feedback-loop between telomerase activity and stemness factors regulates PDAC stem cells
    Karolin Walter, Eva Rodríguez-Aznar, Mónica S. Ventura Ferreira, Pierre‐Olivier Frappart, Tabea Dittrich, Kanishka Tiwary, Sabine Meessen, Laura Lerma, Nora Daiß, Lucas-Alexander Schulte et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  74. TERT promoter mutations
    Frank Gaillard, Paul Ryan, Calum Worsley · 2017 · Radiopaedia.org
  75. Telomerase reverse transcriptase (TERT) : promoter mutation and novel function in human cancer
    Tiantian Liu · 2014 · Figshare
  76. Augmentation of Ras-induced cell transformation : a new role for miR-200a in malignancy.
    Lindsey Becker · 2014
  77. TELOMERASE ACTIVATION AND ITS CLINICAL IMPLICATIONS IN HUMAN THYROID TUMORS
    Na Wang · 2015 · Figshare
  78. Telomerase mutations and carcinogenesis
    Zhiming Cai, XiaoQiang GUO, WeiRen HUANG · 2015 · Chinese Science Bulletin (Chinese Version)
  79. Improving DNA Quality using FFPE tissues for Array Comparative Genomic Hybridization to find Single Nucleotide Polymorphisms (SNPs) in Melanoma
    Keerti Potluri · 2015 · OhioLink ETD Center (Ohio Library and Information Network)
  80. The genetics of Papillary Microcarcinomas of the thyroid
    Gustavo Branquinho Crespo Teixeira Santos · 2016 · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
  81. Learning from new perspectives: Using sparse data and multiple views to predict cancer progression and treatment
    Kiley S. Graim · 2016 · eScholarship (California Digital Library)
  82. Prevalencia, en carcinomas papilares de tiroides metastásicos, de mutaciones somáticas activan tes en la región promotora de TERT
    Dirigido Por Dra, Ginesa García‐Rostán · 2016 · University of Valladolid Documentary Repository (University of Valladolid)
  83. Molecular Genetics of Thyroid Cancer
    Laura N. Purcell, Jen Jen Yeh · 2017 · Springer eBooks
  84. Utilization of a repository of thyroid tumours: clinico-pathological and molecular characterization
    Ana Pestana · 2014 · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
  85. Neoplasia of the Gastrointestinal Tract
    Ofer Margalit, Raymond N. DuBois · 2015 · Wiley eBooks
  86. Hundreds of Putative Non-Coding Cis-Regulatory Drivers in Chronic Lymphocytic Leukaemia and Skin Cancer
    Halit Ongen, Olivier Delaneau, Michael W. Stevens, Cédric Howald, Emmanouil T. Dermitzakis · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
  87. Molecular Classification of Hepatocellular Carcinoma and Precision Medicine
    Michael Feely · 2017 · Molecular pathology library
  88. The association of NF2 (neurofibromin 2) gene polymorphism and the risk of medulloblastomas
    Cailei Zhao, Qian Chen, Chunde Li, Jian Yang, Cong Li, Yangyang Zhou, Jianxiang Liao · 2018 · Neurological Sciences
  89. From Bedside to Endoscopy to Microscopy to Diagnosis: Samples Collection and Processing
    Esther Chaewon Yoon, Minghao Zhong · 2018 · Springer eBooks
  90. Algorithms for deciphering cancer genomes: from differential mutation to differential allele specific expression
    Pawel F. Przytycki · 2018
  91. Pitfalls in Molecular-Based Diagnoses Using Thyroid Aspirates in Korea
    Ju Yeon Pyo, Soon Won Hong · 2019 · Springer eBooks
  92. Telomere-Related Gene Mutations and Lung Diseases: Pulmonary Fibrosis, Emphysema and Lung Cancer
    Leandro Sastre, María Molina‐Molina, Rosario Perona · 2019 · Barcelona Respiratory Network
  93. Convergent mutations in tissue-specific regulatory regions reveal novel cancer drivers
    Nasa Sinnott-Armstrong, José Antonio Seoane, Richard C. Sallari, Jonathan K. Pritchard, Christina N. Curtis, Michael P. Snyder · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  94. Emerging Meningioma Therapies I: Precision Medicine, Targeted Therapies, and Mutation-Specific Approaches
    Ashley M. Roque, Antonio M. P. Omuro · 2020 · Springer eBooks
  95. Role of Noncoding Single Nucleotide Variants on Transcription Factors’ activity in Cancer
    Parisa Mazrooei · 2019 · TSpace (University of Toronto)
  96. Sensitive Detection of Molecular Targets in Cancer by Minisequencing
    Şirin Yüksel, Cemaliye Boylu Akyerli · 2021 · Acibadem Universitesi Saglik Bilimleri Dergisi
  97. Immunohistochemical Surrogates for Molecular Pathology
    Ayça Erşen Danyeli · 2021 · Molecular pathology library
  98. Computational cancer genomics
    Aman Chandra Kaushik, Shakti Sahi · 2021 · Elsevier eBooks
  99. Pediatric Surgical Pathology of the Thyroid and Parathyroid
    Gino R. Somers · 2021 · Springer eBooks
  100. Genomic alteration in thyroid tumors
    Tetsuo Kondo · 2021 · 日本臨床細胞学会雑誌